生泰

0.00 (0.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

74.9097成交張數10.08本益比1.30股價淨值比5.34%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	32	26	18.6%	3.43	57.79	13.3%	10.8%	0.4	0.3
2026Q1	30	25	17.8%	3.41	55.70	10.5%	8.7%	0.4	0.3
2025Q4	30	26	12.5%	5.03	58.09	10.2%	9.0%	2.6	2.4
2025Q3	27	25	7.7%	9.13	55.92	10.5%	9.7%	0.7	0.7
2025Q2	30	24	18.1%	3.18	54.19	12.6%	10.4%	1.1	1.1
2025Q1	29	24	17.1%	3.30	53.81	16.4%	13.3%	1.2	1.0
2024Q4	29	26	10.2%	6.08	57.41	16.1%	13.7%	1.5	0.1
2024Q3	27	25	8.8%	7.76	55.26	13.8%	11.6%	3.3	3.1
2024Q2	28	23	15.7%	3.71	52.64	13.4%	10.7%	0.8	0.6
2024Q1	28	22	20.8%	2.69	50.43	12.5%	9.6%	0.6	0.2
2023Q4	29	23	20.1%	2.80	51.97	11.1%	8.8%	0.7	0.3
2023Q3	30	23	22.8%	2.51	51.38	11.2%	8.3%	1.0	0.3
2023Q2	29	22	24.3%	2.46	49.31	13.3%	9.8%	0.5	-0.2
2023Q1	28	21	24.5%	2.51	47.79	13.6%	10.0%	0.4	-0.7
2022Q4	28	22	20.9%	3.17	49.32	11.9%	8.7%	0.3	-0.6
2022Q3	30	22	27.9%	2.55	48.66	12.8%	8.7%	2.8	2.0
2022Q2	26	18	28.3%	2.65	46.17	8.4%	5.9%	0.6	-0.5
2022Q1	26	19	28.5%	2.74	46.60	5.5%	3.8%	0.7	0.4
2021Q4	27	18	32.3%	2.51	45.73	6.8%	4.6%	0.7	0.4
2021Q3	20	12	38.1%	1.96	40.67	11.3%	7.3%	0.1	0.0
2021Q2	19	13	31.2%	2.47	43.74	11.5%	7.6%	0.4	0.2
2021Q1	19	13	31.0%	2.21	43.00	15.3%	10.3%	0.1	-0.0
2020Q4	18	12	30.4%	2.20	41.27	15.6%	10.3%	1.2	1.2
2020Q3	18	12	31.4%	2.10	40.13	15.7%	10.3%	0.2	0.0
2020Q2	19	12	36.7%	1.80	39.00	18.3%	11.0%	1.2	1.0
2020Q1	19	12	35.2%	1.91	40.16	14.2%	8.8%	0.6	0.5
2019Q4	19	12	37.7%	1.77	38.59	14.1%	8.6%	0.9	0.8
2019Q3	18	11	37.5%	1.77	37.46	15.3%	9.3%	0.7	0.7
2019Q2	19	11	43.3%	1.55	35.65	13.2%	7.6%	0.4	0.3
2019Q1	19	11	39.8%	1.71	37.89	15.6%	9.4%	0.3	0.2
2018Q4	18	11	39.8%	1.61	36.56	14.7%	9.1%	0.7	0.6
2018Q3	18	11	40.7%	1.56	35.24	12.8%	7.9%	-0.1	-0.2
2018Q2	17	10	41.0%	1.54	34.27	11.2%	7.0%	0.9	0.7
2018Q1	17	10	39.2%	1.55	34.00	8.1%	5.5%	0.4	0.1
2017Q4	16	10	36.0%	1.65	33.14	5.9%	4.2%	-0.3	-0.5
2017Q3	15	10	35.9%	1.69	32.20	8.7%	6.2%	0.0	-0.4
2017Q2	14	10	33.5%	1.84	31.87	10.4%	7.3%	0.6	0.4
2017Q1	13	10	22.7%	2.94	34.27	11.0%	8.8%	0.0	-0.4
2016Q4	13	10	20.2%	3.69	34.18	–	–	0.7	0.4
2016Q3	12	10	19.2%	4.24	32.78	–	–	1.1	0.9